Company Filing History:
Years Active: 2007-2012
Title: Innovations of Jason (Qishen) Lin
Introduction
Jason (Qishen) Lin is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of medicinal chemistry, particularly in the development of protein kinase inhibitors. With a total of 2 patents, his work has the potential to impact therapeutic strategies for various diseases.
Latest Patents
Jason Lin's latest patents focus on aminoheteroaryl compounds as protein kinase inhibitors. These include aminopyridine and aminopyrazine compounds of formula (1). The compositions he has developed, along with methods of their use, highlight preferred compounds that exhibit activity as protein kinase inhibitors, including inhibitors of c-MET. This innovative approach could lead to advancements in targeted therapies.
Career Highlights
Throughout his career, Jason has worked with notable companies such as Pfizer Corporation and Sugen Incorporated. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.
Collaborations
Jason has collaborated with talented individuals in his field, including Jingrong Jean Cui and Dilip Ramakant Bhumralkar. These partnerships have contributed to the success of his projects and the advancement of his research.
Conclusion
Jason (Qishen) Lin is a prominent figure in the realm of medicinal chemistry, with a focus on developing innovative protein kinase inhibitors. His contributions through patents and collaborations reflect his commitment to advancing healthcare solutions.